Stonepine Capital Management, LLC Quant / Systematic

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value: $238M (100.0% shares, 0.0% debt)

Holdings (19)

AMRYT PHARMA PLC - SPNR ADR 19.4%
Value $46.23M Shares 6,333,239 Est. Cost $12.34 Unrealized
APOLLO ENDOSURGERY INC 15.6%
Value $37.15M Shares 3,726,584 Est. Cost $6.44 Unrealized
CTI BIOPHARMA CORP 12.5%
Value $29.65M Shares 4,934,100 Est. Cost $3.66 Unrealized
ADMA ADMA BIOLOGICS INC 11.3%
Value $26.93M Shares 6,940,000 Est. Cost $1.81 Unrealized +70.5%
QDEL QUIDELORTHO CORP 10.8%
Value $25.7M Shares 300,000 Est. Cost $92.45 Unrealized -8.4%
XERS XERIS BIOPHARMA HOLDINGS INC 6.3%
Value $14.89M Shares 11,195,189 Est. Cost $2.15 Unrealized -34.2%
URGN UROGEN PHARMA LTD 4.9%
Value $11.57M Shares 1,304,947 Est. Cost $7.43 Unrealized +27.4%
THIRD HARMONIC BIO INC 3.6%
Value $8.666M Shares 2,015,301 Est. Cost $4.30 Unrealized
GLPG GALAPAGOS NV-SPON ADR 3.6%
Value $8.647M Shares 194,836 Est. Cost $44.38 Unrealized
EOLS EVOLUS INC 2.6%
Value $6.267M Shares 834,432 Est. Cost $8.43 Unrealized -8.1%
RZLT REZOLUTE INC 2.6%
Value $6.255M Shares 3,021,504 Est. Cost $3.92 Unrealized -52.2%
CSTL CASTLE BIOSCIENCES INC 1.8%
Value $4.196M Shares 178,240 Est. Cost $23.18 Unrealized 0.0%
CONFORMIS INC 1.0%
Value $2.484M Shares 748,194 Est. Cost $0.75 Unrealized
MIRM MIRUM PHARMACEUTICALS INC 0.9%
Value $2.121M Shares 108,769 Est. Cost $19.77 Unrealized 0.0%
XGN EXAGEN INC 0.9%
Value $2.05M Shares 854,042 Est. Cost $11.52 Unrealized -77.7%
MXCT MAXCYTE INC 0.6%
Value $1.492M Shares 273,287 Est. Cost $6.13 Unrealized 0.0%
OABI OMNIAB INC 0.5%
Value $1.275M Shares 354,266 Est. Cost $5.33 Unrealized 0.0%
XOMA XOMA CORP 0.5%
Value $1.186M Shares 64,459 Est. Cost $20.39 Unrealized -10.9%
OPTINOSE INC 0.4%
Value $940K Shares 508,284 Est. Cost $1.62 Unrealized